Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

CSL Behring at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

CSL Behring brings 3 presentations to ASH 2026 in New Orleans. Its research spans real-world outcomes in blood and iron disorders and the biology of sickle cell disease. It covers hereditary hemochromatosis, infection treatment in myeloma, and blocking a receptor to calm neutrophils in sickle cell disease.

OrganizationASH 2026 Attendance
CSL Behring
King of Prussia, PA
Large pharma1 exhibitor meeting room
Biopharmaceutical company developing and supplying therapies for bleeding disorders and other conditions.
Exhibitor meeting room at the convention center, no exhibit-hall booth

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at CSL Behring

Tell us what you sell and we’ll find the people at CSL Behring most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction